Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05967741 · ClinicalTrials.gov registry record · NA
The Effects of Dietary Erythritol on Platelet Reactivity and Vascular Inflammation
A NA study of Platelet Aggregation, Spontaneous and Vascular Thrombosis, sponsored by University of California, Davis.
- Recruiting
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT05967741 is a NA study of Platelet Aggregation, Spontaneous and Vascular Thrombosis that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 24 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05967741, a NA study of Platelet Aggregation, Spontaneous and Vascular Thrombosis, is actively recruiting participants, sponsored by University of California, Davis.
- RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose is to conduct a dietary intervention study in which human participants will consume beverages sweetened with erythritol or aspartame, each for 2 weeks, in a randomized crossover design
Conditions Studied
Interventions
- OTHER Erythritol
- OTHER Aspartame
Study Locations (1)
California
- Ragle Human Nutrition Research Center, University of California, Davis - Davis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2023-07-20 |
| Est. Completion | 2026-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05967741
The ClinicalTrials.gov registry entry for NCT05967741 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Platelet Aggregation, Spontaneous appearing as the primary indexed condition, and to 2 interventions - of which Erythritol is the first listed.
NCT05967741 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05967741 about?
NCT05967741 is a clinical study titled "The Effects of Dietary Erythritol on Platelet Reactivity and Vascular Inflammation". The purpose is to conduct a dietary intervention study in which human participants will consume beverages sweetened with erythritol or aspartame, each for 2 weeks, in a randomized crossover design
What is the current status of trial NCT05967741?
This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2023-07-20. Estimated completion is 2026-06.
What conditions does trial NCT05967741 study?
This clinical trial studies the following conditions: Platelet Aggregation, Spontaneous, Vascular Thrombosis.
What interventions are being tested in trial NCT05967741?
The interventions under investigation include: Erythritol (OTHER), Aspartame (OTHER).
Who is sponsoring clinical trial NCT05967741?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05967741 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Platelet Aggregation, Spontaneous
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.